Facebook
X
LinkedIn
ForwardRadiopharmaceutical Therapy Administration and the Role of the QMP
Session describes the logistics behind radiopharmaceutical therapy (RPT) administration, starting with drug receipt, preparation, infusion, and finishing with patient release. The session highlights the role of the qualified medical physicist (QMP) in ensuring safety, quality, and regulatory compliance for RPT administration. This session includes a panel of two QMPs from academic and community-hospital settings sharing their experience with regard to RPT administration, procedure development, and training.
Target Audience
This meeting was designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists, radiation therapists, radiation dosimetrists, specialists, nuclear physicians and practice administrators.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Learn about drug preparation.
- Learn about methods for therapy infusion.
- Learn about patient release and radiation safety considerations.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 Certificate of AttendanceThis activity was designated for 0.50 AMA PRA Category 1 Credit™.